期刊文献+

VEGF、ER、PR在异位和在位子宫内膜中的表达 被引量:5

The Expression of VEGF,ER,PR in Ectopic Endometrium and Eutopic Endometrium of EM Patients
下载PDF
导出
摘要 研究血管内皮因子(VEGF)、雌激素受体(ER)和孕激素受体(PR)在子宫内膜异位症(EM)患者的异位和在位内膜中的表达.采用免疫组化SP法分别检测45例EM(研究组)的异位和在位内膜及32例子宫肌瘤(对照组)的在位内膜中VEGF、ER、PR的表达.利用图像分析仪测定的相应密度代表其表达强度.研究组异位和在位内膜中VEGF的表达均显著高于对照组内膜(p<0.01),ER/PR则显著低于对照组内膜;ER、PR仅于异位内膜中的表达低于对照组内膜,异位内膜中VEGF与ER呈正相关.异位内膜和在位内膜中高VEGF和低ER/PR以及异位内膜中VEGF与ER正相关的特点可能与EM的发生发展有关. This paper studies the expression of VEGF,ER and PR in ectopic and eutopic endometrium in patients who suffer from endometriosis. Using immunohistochemistry SP method, we examine respectively the expression of VEGF, ER and PR in ectopic and eutopic endometrium of 45 EM cases (study group), and the expression of VEGF,ER and PR in eutopic endometrium of 32 cases of uterine fibroid (control group). Image dissector shows that the corresponding density represents its expression intensity. The expression of VEGF is remarkably higher in the ectopic endometrium and eutopic endometrium of study group than the endometrium of control group (p〈0.01) ER/PR are remarkably lower than the endometrium of control group. ER and PR are lower than the endometrium of control group only in the expression of ectopic endometrium while VEGF in ectopic endometrium is positively related to ER. The high VEGF and low ER/PR in ectopic and eutopic endometrium, together with the fact that VEGF and ER are positively related in ectopic endometrium, may be the cause of the pathogenesis of EM.
出处 《厦门大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第6期870-873,共4页 Journal of Xiamen University:Natural Science
基金 厦门市科研基金(2001V4)资助
关键词 异位内膜 在位内膜 VEGF ER PR ectopic endometrium eutopic endometrium VEGF ER PR
  • 相关文献

参考文献8

二级参考文献12

  • 1汪玉宝.子宫内膜异位症的病理学研究近况[J].国外医学(妇产科学分册),1994,21(2):88-91. 被引量:9
  • 2王振法.血液病诊断及图谱[M].新华出版社,1997.26-36.
  • 3Ishimura T, Masuzaki H. Peritoneal endometriosis: endometrial tissue implantation as its primary etiologic mechanism[ J ]. Am J Obstet Gyneeol, 1991, 165( 1 ) :210-214.
  • 4Folkman J, Shing Y. Angiogenesis[ J]. J Biol Chem, 1992, 267(16) : 10931-10934.
  • 5Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis [ J ]. Hum Reprod,1998, 13(6) : 1686-1690.
  • 6Dvorak HF, Brown LF, Detmar M, et al. Vasclular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis[ J]. Am J Pathol, 1995, 146 : 1029-1039.
  • 7Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation[J]. TIBS, 1997, 22(7) :251-256.
  • 8McLaren J, Prentice A, Charnock-Jones DS, et al. Vascular endothelail growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids [ J ]. J Clin Invest, 1996, 98:482-489.
  • 9Fujishita A, Hasuo A, Khan KN, et al. Immunohistochemical study of angiogenic factor in endometrium and endometriosis[ J ].Gynecol Obstet Invest, 1999, 48( suppl 1 ) : 36--44.
  • 10Smith SK. Vascular endothelial growth factor and the endometrium[J]. Hum Reprod, 1996, 11: 56-61.

共引文献608

同被引文献52

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部